107 related articles for article (PubMed ID: 30354907)
41. Effects of Treatment of Uterine Cervical Carcinoma Monitored by Magnetic Resonance Imaging - Sarajevo Experience.
Sofic A; Husic-Selimovic A; Beslic N; Rasic A; Begic D; Tomic-Cica A; Imsirevic N
Acta Inform Med; 2017 Mar; 25(1):39-43. PubMed ID: 28484296
[TBL] [Abstract][Full Text] [Related]
42. Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
Halle MK; Hodneland E; Wagner-Larsen KS; Lura NG; Fasmer KE; Berg HF; Stokowy T; Srivastava A; Forsse D; Hoivik EA; Woie K; Bertelsen BI; Krakstad C; Haldorsen IS
Sci Rep; 2024 May; 14(1):11339. PubMed ID: 38760387
[TBL] [Abstract][Full Text] [Related]
43. Unsolved Issues in Thymic Epithelial Tumour Stage Classification: The Role of Tumour Dimension.
Sassorossi C; Bertoglio P; Lococo F; Santoro G; Meacci E; Nachira D; Congedo MT; Brandolini J; Petroncini M; Nocera A; Charles-Davies D; Solli P; Margaritora S; Chiappetta M
Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998604
[TBL] [Abstract][Full Text] [Related]
44. Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma.
Bluemke E; Bulte D; Bertrand A; George B; Cooke R; Chu KY; Durrant L; Goh V; Jacobs C; Ng SM; Strauss VY; Hawkins MA; Muirhead R
Clin Transl Radiat Oncol; 2020 May; 22():44-49. PubMed ID: 32211520
[TBL] [Abstract][Full Text] [Related]
45. Can Radiological Tumour Thickness Predict Pathological Prognostic Factors in Clinicoradiologically Node-Negative Oral Squamous Carcinoma? A Prospective Study.
Das K; Dey R; Nath J; Das A; Kakati K; Barman G; Kakoti L
Indian J Otolaryngol Head Neck Surg; 2024 Apr; 76(2):1836-1840. PubMed ID: 38566693
[TBL] [Abstract][Full Text] [Related]
46. Value of non-coding RNAs to assess lymph node status in cervical cancer.
Dabi Y; Favier A; Razakamanantsoa L; Suisse S; Marie Y; Touboul C; Ferrier C; Bendifallah S; Daraï E
Front Oncol; 2023; 13():1144672. PubMed ID: 37234986
[TBL] [Abstract][Full Text] [Related]
47. Imaging Findings of Calcifying Nested Stromal-Epithelial Tumour of the Liver: A Case Report and Literature Review.
Cai E; Zheng Y; Wang M; Zeng M
Curr Med Imaging; 2024 Apr; ():. PubMed ID: 38639283
[TBL] [Abstract][Full Text] [Related]
48. Comment on "Definite chemoradiotherapy for early-stage bulky cervical cancer".
Zhang W; Ruan Y; Ye L; Liu M
J Formos Med Assoc; 2024 Mar; 123(3):416-417. PubMed ID: 37291045
[No Abstract] [Full Text] [Related]
49. Predictors of cervical tumour size for outpatients with cervical cancer at the University of Gondar referral hospital: a retrospective study design.
Gashu C; Aguade AE
Eur J Med Res; 2023 Oct; 28(1):453. PubMed ID: 37872641
[TBL] [Abstract][Full Text] [Related]
50. Exercise during treatment for advanced cervical cancer.
Tórtola-Navarro A; Martínez-García J; Cano-Martínez A; Serradilla A
BMJ Support Palliat Care; 2024 Jan; 13(e3):e960-e963. PubMed ID: 36792345
[TBL] [Abstract][Full Text] [Related]
51. Molecular mechanisms of hypoxia in cancer.
Challapalli A; Carroll L; Aboagye EO
Clin Transl Imaging; 2017; 5(3):225-253. PubMed ID: 28596947
[TBL] [Abstract][Full Text] [Related]
52. Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance.
Johnston CD; Bullman S
Trends Cancer; 2024 Feb; 10(2):97-99. PubMed ID: 38242824
[TBL] [Abstract][Full Text] [Related]
53. Response to comment on "Definite chemoradiotherapy for early-stagebulky cervical cancer".
Hsieh HY; Lu CH; Wang L
J Formos Med Assoc; 2024 Mar; 123(3):418-419. PubMed ID: 38129266
[No Abstract] [Full Text] [Related]
54. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
Ho JC; Fang P; Cardenas CE; Mohamed ASR; Fuller CD; Allen PK; Bhosale PR; Frumovitz MM; Jhingran A; Klopp AH
Radiother Oncol; 2019 Jun; 135():58-64. PubMed ID: 31015171
[TBL] [Abstract][Full Text] [Related]
55. Post treatment imaging in patients with local advanced cervical carcinoma.
Ciulla S; Celli V; Aiello AA; Gigli S; Ninkova R; Miceli V; Ercolani G; Dolciami M; Ricci P; Palaia I; Catalano C; Manganaro L
Front Oncol; 2022; 12():1003930. PubMed ID: 36465360
[TBL] [Abstract][Full Text] [Related]
56. Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy.
Dolciami M; Capuani S; Celli V; Maiuro A; Pernazza A; Palaia I; Di Donato V; Santangelo G; Rizzo SMR; Ricci P; Della Rocca C; Catalano C; Manganaro L
J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455755
[TBL] [Abstract][Full Text] [Related]
57. A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy.
Han L; Wang Q; Zhao L; Feng X; Wang Y; Zou Y; Li Q
Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359345
[TBL] [Abstract][Full Text] [Related]
58. Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review.
Decazes P; Hinault P; Veresezan O; Thureau S; Gouel P; Vera P
Front Oncol; 2020; 10():614008. PubMed ID: 33614497
[TBL] [Abstract][Full Text] [Related]
59. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
